Loading…
Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?
Mucopolysaccharidosis IIIA is a hereditary disease caused by mutations in the sulfamidase enzyme that participates in catabolism of heparan sulfate (HS), leading to HS fragment accumulation and multisystemic failure. No cure exists and death occurs around the second decade of life. Two low molecular...
Saved in:
Published in: | Carbohydrate polymers 2023-11, Vol.320, p.121214-121214, Article 121214 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3 |
container_end_page | 121214 |
container_issue | |
container_start_page | 121214 |
container_title | Carbohydrate polymers |
container_volume | 320 |
creator | Veraldi, Noemi Quadri, Isabelle Dentand van de Looij, Yohan Modernell, Laura Malaguti Sinquin, Corinne Zykwinska, Agata Tournier, Benjamin B. Dalonneau, Fabien Li, Honglian Li, Jin-Ping Millet, Philippe Vives, Romain Colliec-Jouault, Sylvia de Agostini, Ariane Sanches, Eduardo Farias Sizonenko, Stéphane V. |
description | Mucopolysaccharidosis IIIA is a hereditary disease caused by mutations in the sulfamidase enzyme that participates in catabolism of heparan sulfate (HS), leading to HS fragment accumulation and multisystemic failure. No cure exists and death occurs around the second decade of life. Two low molecular weight highly sulfated compounds derived from marine diabolican and infernan exopolysaccharides (A5_3 and A5_4, respectively) with heparanase inhibiting properties were tested in a MPSIIIA cell line model, resulting in limited degradation of intracellular HS. Next, we observed the effects of intraperitoneal injections of the diabolican derivative A5_3 from 4 to 12 weeks of age on MPSIIIA mice. Brain metabolism and microstructure, levels of proteins and genes involved in MPSIIIA brain pathophysiology were also investigated. 1H-Magnetic Resonance Spectroscopy (MRS) indicated deficits in energetic metabolism, tissue integrity and neurotransmission at both 4 and 12 weeks in MPSIIIA mice, with partial protective effects of A5_3. Ex-vivo Diffusion Tensor Imaging (DTI) showed white matter microstructural damage in MPSIIIA, with noticeable protective effects of A5_3. Protein and gene expression assessments displayed both pro-inflammatory and pro-apoptotic profiles in MPSIIIA mice, with benefits of A5_3 counteracting neuroinflammation. Overall, derivative A5_3 was well tolerated and was shown to be efficient in preventing brain metabolism failure and inflammation, resulting in preserved brain microstructure in the context of MPSIIIA.
[Display omitted] |
doi_str_mv | 10.1016/j.carbpol.2023.121214 |
format | article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_DiVA_org_uu_510139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0144861723006793</els_id><sourcerecordid>2860407250</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3</originalsourceid><addsrcrecordid>eNqFkd1q2zAYhsVYYVm3SxjocIM507_tnZTQbmsg0B5sOxWy_DlRcCxPshJ6Ab3vKTgMejTpQEg83wN6X4Q-ULKkhKov-6U1oRl9v2SE8SVleYtXaEGrsi4oF-I1WhAqRFEpWr5Bb2Pck7wUJQv0vPGn4uB7sKk3AZ_AbXcTjqnvzAQtPpjgBsDZ_RSNtbt8bSF-xY_BH1x0wxZfZiHiyeMxwBGGCQ-Qgm9hCwMEMzk_YDfgQ7L-hchHF_F6vV7dvENXnekjvL-c1-jX928_b--LzcOP9e1qU1ihyFQwVRouhVBdqWhlm4bXYHhLoJGUEym7zlaMAVMNlbKWiotW8pJRwxRlrAZ-jT7P3niCMTV6DC7_8El74_Sd-73SPmx1SlrmXHmd8U8zvjP9C_Z-tdHnNyIYEVl9pJn9OLNj8H8SxEnngCz0vRnAp6hZpYggJZMko3JGbfAxBuj-uSnR50b1Xl8a1edG9dxonruZ5yBHdHQQdLQOBgutC2An3Xr3H8NfZ8mtyA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860407250</pqid></control><display><type>article</type><title>Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?</title><source>ScienceDirect Journals</source><creator>Veraldi, Noemi ; Quadri, Isabelle Dentand ; van de Looij, Yohan ; Modernell, Laura Malaguti ; Sinquin, Corinne ; Zykwinska, Agata ; Tournier, Benjamin B. ; Dalonneau, Fabien ; Li, Honglian ; Li, Jin-Ping ; Millet, Philippe ; Vives, Romain ; Colliec-Jouault, Sylvia ; de Agostini, Ariane ; Sanches, Eduardo Farias ; Sizonenko, Stéphane V.</creator><creatorcontrib>Veraldi, Noemi ; Quadri, Isabelle Dentand ; van de Looij, Yohan ; Modernell, Laura Malaguti ; Sinquin, Corinne ; Zykwinska, Agata ; Tournier, Benjamin B. ; Dalonneau, Fabien ; Li, Honglian ; Li, Jin-Ping ; Millet, Philippe ; Vives, Romain ; Colliec-Jouault, Sylvia ; de Agostini, Ariane ; Sanches, Eduardo Farias ; Sizonenko, Stéphane V.</creatorcontrib><description>Mucopolysaccharidosis IIIA is a hereditary disease caused by mutations in the sulfamidase enzyme that participates in catabolism of heparan sulfate (HS), leading to HS fragment accumulation and multisystemic failure. No cure exists and death occurs around the second decade of life. Two low molecular weight highly sulfated compounds derived from marine diabolican and infernan exopolysaccharides (A5_3 and A5_4, respectively) with heparanase inhibiting properties were tested in a MPSIIIA cell line model, resulting in limited degradation of intracellular HS. Next, we observed the effects of intraperitoneal injections of the diabolican derivative A5_3 from 4 to 12 weeks of age on MPSIIIA mice. Brain metabolism and microstructure, levels of proteins and genes involved in MPSIIIA brain pathophysiology were also investigated. 1H-Magnetic Resonance Spectroscopy (MRS) indicated deficits in energetic metabolism, tissue integrity and neurotransmission at both 4 and 12 weeks in MPSIIIA mice, with partial protective effects of A5_3. Ex-vivo Diffusion Tensor Imaging (DTI) showed white matter microstructural damage in MPSIIIA, with noticeable protective effects of A5_3. Protein and gene expression assessments displayed both pro-inflammatory and pro-apoptotic profiles in MPSIIIA mice, with benefits of A5_3 counteracting neuroinflammation. Overall, derivative A5_3 was well tolerated and was shown to be efficient in preventing brain metabolism failure and inflammation, resulting in preserved brain microstructure in the context of MPSIIIA.
[Display omitted]</description><identifier>ISSN: 0144-8617</identifier><identifier>ISSN: 1879-1344</identifier><identifier>EISSN: 1879-1344</identifier><identifier>DOI: 10.1016/j.carbpol.2023.121214</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><subject>Chemical Sciences ; Heparan sulfate ; Life Sciences ; Magnetic spectroscopy resonance ; Marine polysaccharides ; Medicinal Chemistry ; Mucopolysaccharidosis ; Neurobiology ; Neurons and Cognition</subject><ispartof>Carbohydrate polymers, 2023-11, Vol.320, p.121214-121214, Article 121214</ispartof><rights>2023 The Authors</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3</citedby><cites>FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3</cites><orcidid>0000-0001-7093-3832 ; 0000-0002-8930-9535 ; 0000-0002-2449-5410</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04204122$$DView record in HAL$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-510139$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Veraldi, Noemi</creatorcontrib><creatorcontrib>Quadri, Isabelle Dentand</creatorcontrib><creatorcontrib>van de Looij, Yohan</creatorcontrib><creatorcontrib>Modernell, Laura Malaguti</creatorcontrib><creatorcontrib>Sinquin, Corinne</creatorcontrib><creatorcontrib>Zykwinska, Agata</creatorcontrib><creatorcontrib>Tournier, Benjamin B.</creatorcontrib><creatorcontrib>Dalonneau, Fabien</creatorcontrib><creatorcontrib>Li, Honglian</creatorcontrib><creatorcontrib>Li, Jin-Ping</creatorcontrib><creatorcontrib>Millet, Philippe</creatorcontrib><creatorcontrib>Vives, Romain</creatorcontrib><creatorcontrib>Colliec-Jouault, Sylvia</creatorcontrib><creatorcontrib>de Agostini, Ariane</creatorcontrib><creatorcontrib>Sanches, Eduardo Farias</creatorcontrib><creatorcontrib>Sizonenko, Stéphane V.</creatorcontrib><title>Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?</title><title>Carbohydrate polymers</title><description>Mucopolysaccharidosis IIIA is a hereditary disease caused by mutations in the sulfamidase enzyme that participates in catabolism of heparan sulfate (HS), leading to HS fragment accumulation and multisystemic failure. No cure exists and death occurs around the second decade of life. Two low molecular weight highly sulfated compounds derived from marine diabolican and infernan exopolysaccharides (A5_3 and A5_4, respectively) with heparanase inhibiting properties were tested in a MPSIIIA cell line model, resulting in limited degradation of intracellular HS. Next, we observed the effects of intraperitoneal injections of the diabolican derivative A5_3 from 4 to 12 weeks of age on MPSIIIA mice. Brain metabolism and microstructure, levels of proteins and genes involved in MPSIIIA brain pathophysiology were also investigated. 1H-Magnetic Resonance Spectroscopy (MRS) indicated deficits in energetic metabolism, tissue integrity and neurotransmission at both 4 and 12 weeks in MPSIIIA mice, with partial protective effects of A5_3. Ex-vivo Diffusion Tensor Imaging (DTI) showed white matter microstructural damage in MPSIIIA, with noticeable protective effects of A5_3. Protein and gene expression assessments displayed both pro-inflammatory and pro-apoptotic profiles in MPSIIIA mice, with benefits of A5_3 counteracting neuroinflammation. Overall, derivative A5_3 was well tolerated and was shown to be efficient in preventing brain metabolism failure and inflammation, resulting in preserved brain microstructure in the context of MPSIIIA.
[Display omitted]</description><subject>Chemical Sciences</subject><subject>Heparan sulfate</subject><subject>Life Sciences</subject><subject>Magnetic spectroscopy resonance</subject><subject>Marine polysaccharides</subject><subject>Medicinal Chemistry</subject><subject>Mucopolysaccharidosis</subject><subject>Neurobiology</subject><subject>Neurons and Cognition</subject><issn>0144-8617</issn><issn>1879-1344</issn><issn>1879-1344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkd1q2zAYhsVYYVm3SxjocIM507_tnZTQbmsg0B5sOxWy_DlRcCxPshJ6Ab3vKTgMejTpQEg83wN6X4Q-ULKkhKov-6U1oRl9v2SE8SVleYtXaEGrsi4oF-I1WhAqRFEpWr5Bb2Pck7wUJQv0vPGn4uB7sKk3AZ_AbXcTjqnvzAQtPpjgBsDZ_RSNtbt8bSF-xY_BH1x0wxZfZiHiyeMxwBGGCQ-Qgm9hCwMEMzk_YDfgQ7L-hchHF_F6vV7dvENXnekjvL-c1-jX928_b--LzcOP9e1qU1ihyFQwVRouhVBdqWhlm4bXYHhLoJGUEym7zlaMAVMNlbKWiotW8pJRwxRlrAZ-jT7P3niCMTV6DC7_8El74_Sd-73SPmx1SlrmXHmd8U8zvjP9C_Z-tdHnNyIYEVl9pJn9OLNj8H8SxEnngCz0vRnAp6hZpYggJZMko3JGbfAxBuj-uSnR50b1Xl8a1edG9dxonruZ5yBHdHQQdLQOBgutC2An3Xr3H8NfZ8mtyA</recordid><startdate>20231115</startdate><enddate>20231115</enddate><creator>Veraldi, Noemi</creator><creator>Quadri, Isabelle Dentand</creator><creator>van de Looij, Yohan</creator><creator>Modernell, Laura Malaguti</creator><creator>Sinquin, Corinne</creator><creator>Zykwinska, Agata</creator><creator>Tournier, Benjamin B.</creator><creator>Dalonneau, Fabien</creator><creator>Li, Honglian</creator><creator>Li, Jin-Ping</creator><creator>Millet, Philippe</creator><creator>Vives, Romain</creator><creator>Colliec-Jouault, Sylvia</creator><creator>de Agostini, Ariane</creator><creator>Sanches, Eduardo Farias</creator><creator>Sizonenko, Stéphane V.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0001-7093-3832</orcidid><orcidid>https://orcid.org/0000-0002-8930-9535</orcidid><orcidid>https://orcid.org/0000-0002-2449-5410</orcidid></search><sort><creationdate>20231115</creationdate><title>Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?</title><author>Veraldi, Noemi ; Quadri, Isabelle Dentand ; van de Looij, Yohan ; Modernell, Laura Malaguti ; Sinquin, Corinne ; Zykwinska, Agata ; Tournier, Benjamin B. ; Dalonneau, Fabien ; Li, Honglian ; Li, Jin-Ping ; Millet, Philippe ; Vives, Romain ; Colliec-Jouault, Sylvia ; de Agostini, Ariane ; Sanches, Eduardo Farias ; Sizonenko, Stéphane V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chemical Sciences</topic><topic>Heparan sulfate</topic><topic>Life Sciences</topic><topic>Magnetic spectroscopy resonance</topic><topic>Marine polysaccharides</topic><topic>Medicinal Chemistry</topic><topic>Mucopolysaccharidosis</topic><topic>Neurobiology</topic><topic>Neurons and Cognition</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veraldi, Noemi</creatorcontrib><creatorcontrib>Quadri, Isabelle Dentand</creatorcontrib><creatorcontrib>van de Looij, Yohan</creatorcontrib><creatorcontrib>Modernell, Laura Malaguti</creatorcontrib><creatorcontrib>Sinquin, Corinne</creatorcontrib><creatorcontrib>Zykwinska, Agata</creatorcontrib><creatorcontrib>Tournier, Benjamin B.</creatorcontrib><creatorcontrib>Dalonneau, Fabien</creatorcontrib><creatorcontrib>Li, Honglian</creatorcontrib><creatorcontrib>Li, Jin-Ping</creatorcontrib><creatorcontrib>Millet, Philippe</creatorcontrib><creatorcontrib>Vives, Romain</creatorcontrib><creatorcontrib>Colliec-Jouault, Sylvia</creatorcontrib><creatorcontrib>de Agostini, Ariane</creatorcontrib><creatorcontrib>Sanches, Eduardo Farias</creatorcontrib><creatorcontrib>Sizonenko, Stéphane V.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><jtitle>Carbohydrate polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veraldi, Noemi</au><au>Quadri, Isabelle Dentand</au><au>van de Looij, Yohan</au><au>Modernell, Laura Malaguti</au><au>Sinquin, Corinne</au><au>Zykwinska, Agata</au><au>Tournier, Benjamin B.</au><au>Dalonneau, Fabien</au><au>Li, Honglian</au><au>Li, Jin-Ping</au><au>Millet, Philippe</au><au>Vives, Romain</au><au>Colliec-Jouault, Sylvia</au><au>de Agostini, Ariane</au><au>Sanches, Eduardo Farias</au><au>Sizonenko, Stéphane V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA?</atitle><jtitle>Carbohydrate polymers</jtitle><date>2023-11-15</date><risdate>2023</risdate><volume>320</volume><spage>121214</spage><epage>121214</epage><pages>121214-121214</pages><artnum>121214</artnum><issn>0144-8617</issn><issn>1879-1344</issn><eissn>1879-1344</eissn><abstract>Mucopolysaccharidosis IIIA is a hereditary disease caused by mutations in the sulfamidase enzyme that participates in catabolism of heparan sulfate (HS), leading to HS fragment accumulation and multisystemic failure. No cure exists and death occurs around the second decade of life. Two low molecular weight highly sulfated compounds derived from marine diabolican and infernan exopolysaccharides (A5_3 and A5_4, respectively) with heparanase inhibiting properties were tested in a MPSIIIA cell line model, resulting in limited degradation of intracellular HS. Next, we observed the effects of intraperitoneal injections of the diabolican derivative A5_3 from 4 to 12 weeks of age on MPSIIIA mice. Brain metabolism and microstructure, levels of proteins and genes involved in MPSIIIA brain pathophysiology were also investigated. 1H-Magnetic Resonance Spectroscopy (MRS) indicated deficits in energetic metabolism, tissue integrity and neurotransmission at both 4 and 12 weeks in MPSIIIA mice, with partial protective effects of A5_3. Ex-vivo Diffusion Tensor Imaging (DTI) showed white matter microstructural damage in MPSIIIA, with noticeable protective effects of A5_3. Protein and gene expression assessments displayed both pro-inflammatory and pro-apoptotic profiles in MPSIIIA mice, with benefits of A5_3 counteracting neuroinflammation. Overall, derivative A5_3 was well tolerated and was shown to be efficient in preventing brain metabolism failure and inflammation, resulting in preserved brain microstructure in the context of MPSIIIA.
[Display omitted]</abstract><pub>Elsevier Ltd</pub><doi>10.1016/j.carbpol.2023.121214</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7093-3832</orcidid><orcidid>https://orcid.org/0000-0002-8930-9535</orcidid><orcidid>https://orcid.org/0000-0002-2449-5410</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0144-8617 |
ispartof | Carbohydrate polymers, 2023-11, Vol.320, p.121214-121214, Article 121214 |
issn | 0144-8617 1879-1344 1879-1344 |
language | eng |
recordid | cdi_swepub_primary_oai_DiVA_org_uu_510139 |
source | ScienceDirect Journals |
subjects | Chemical Sciences Heparan sulfate Life Sciences Magnetic spectroscopy resonance Marine polysaccharides Medicinal Chemistry Mucopolysaccharidosis Neurobiology Neurons and Cognition |
title | Low-molecular weight sulfated marine polysaccharides: Promising molecules to prevent neurodegeneration in mucopolysaccharidosis IIIA? |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T12%3A22%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Low-molecular%20weight%20sulfated%20marine%20polysaccharides:%20Promising%20molecules%20to%20prevent%20neurodegeneration%20in%20mucopolysaccharidosis%20IIIA?&rft.jtitle=Carbohydrate%20polymers&rft.au=Veraldi,%20Noemi&rft.date=2023-11-15&rft.volume=320&rft.spage=121214&rft.epage=121214&rft.pages=121214-121214&rft.artnum=121214&rft.issn=0144-8617&rft.eissn=1879-1344&rft_id=info:doi/10.1016/j.carbpol.2023.121214&rft_dat=%3Cproquest_swepu%3E2860407250%3C/proquest_swepu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c460t-267a35446f7618cbb39ea3d0eb513055ffc822e26b15595634d53721a261229e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2860407250&rft_id=info:pmid/&rfr_iscdi=true |